LF

Lamond Family

Description

Lamond Family

Investor Profile

Lamond Family has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Debt Financing, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Debt Financing (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lamond Family frequently co-invest with?

Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
Breakout Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Pfizer
North America, New York, United States, New York
Co-Investments: 1
EPIQ Capital Group
North America, California, United States, San Francisco
Co-Investments: 1
Huizenga Capital Management
North America, Illinois, United States, Oak Brook
Co-Investments: 1
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2
RS Investments
North America, California, United States, San Francisco
Co-Investments: 1
SW
North America, California, United States, Los Angeles
Co-Investments: 1

What are some of recent deals done by Lamond Family?

Cortexyme

South San Francisco, California, United States

Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMay 31, 2018
Amount Raised: $76,000,000
Cortexyme

South San Francisco, California, United States

Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Debt FinancingApr 14, 2017
Amount Raised: $8,000,000